Literature DB >> 23882435

Valproate-induced hyperammonemic encephalopathy: a case report.

Vikas Mangewala1, Sajjad Sarwar, Ryan Rosenberger, Theodor Rais, Michele Knox.   

Abstract

Entities:  

Year:  2013        PMID: 23882435      PMCID: PMC3719457     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


× No keyword cloud information.
  13 in total

1.  Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.

Authors:  G P Panikkar; S M Gilman
Journal:  J Clin Psychiatry       Date:  1999-08       Impact factor: 4.384

Review 2.  Current aspects of valproate in bipolar disorder.

Authors:  C Lennkh; C Simhandl
Journal:  Int Clin Psychopharmacol       Date:  2000-01       Impact factor: 1.659

3.  Valproate-induced hyperammonemic encephalopathy in the presence of topiramate.

Authors:  H M Hamer; S Knake; U Schomburg; F Rosenow
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

4.  Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.

Authors:  R N Ratnaike; G J Schapel; G Purdie; R H Rischbieth; S Hoffmann
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

5.  Carnitine for valproic acid-induced hyperammonemia.

Authors:  W N Raby
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

6.  Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.

Authors:  B S Zaret; R R Beckner; A M Marini; W Wagle; C Passarelli
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

Review 7.  Valproate-induced hyperammonemic encephalopathy.

Authors:  Alberto Verrotti; Daniela Trotta; Guido Morgese; Francesco Chiarelli
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

8.  Valproic acid-induced hyperammonemia in mentally retarded adults.

Authors:  C A Williams; S Tiefenbach; J W McReynolds
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

Review 9.  Valproate-associated hyperammonemic encephalopathy.

Authors:  Jim Wadzinski; Ronald Franks; David Roane; Max Bayard
Journal:  J Am Board Fam Med       Date:  2007 Sep-Oct       Impact factor: 2.657

10.  Valproic acid and secondary hyperammonemia.

Authors:  S Rawat; W J Borkowski; H M Swick
Journal:  Neurology       Date:  1981-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.